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Abstract
Background: Lim1 is a homeobox gene that is essential for nephrogenesis. During metanephric
kidney development, Lim1  is expressed in the nephric duct, ureteric buds, and the induced
metanephric mesenchyme. Conditional ablation of Lim1 in the metanephric mesenchyme blocks the
formation of nephrons at the nephric vesicle stage, leading to the production of small, non-
functional kidneys that lack nephrons.
Methods: In the present study, we used Affymetrix probe arrays to screen for nephron-specific
genes by comparing the expression profiles of control and Lim1  conditional mutant kidneys.
Kidneys from two developmental stages, embryonic day 14.5 (E14.5) and 18.5 (E18.5), were
examined.
Results: Comparison of E18.5 kidney expression profiles generated a list of 465 nephron-specific
gene candidates that showed a more than 2-fold increase in their expression level in control kidney
versus the Lim1 conditional mutant kidney. Computational analysis confirmed that this screen
enriched for kidney-specific genes. Furthermore, at least twenty-eight of the top fifty (56%)
candidates (or their vertebrate orthologs) were previously reported to have a nephron-specific
expression pattern. Our analysis of E14.5 expression data yielded 41 candidate genes that are up-
regulated in the control kidneys compared to the conditional mutants. Three of them are related
to the Notch signaling pathway that is known to be important in cell fate determination and
nephron patterning.
Conclusion: Therefore, we demonstrate that Lim1 conditional mutant kidneys serve as a novel
tissue source for comprehensive expression studies and provide a means to identify nephron-
specific genes.
Background
Kidney is one of the main excretory and homeostatic
organs of the body. The basic structural and functional
unit of the kidney is the nephron. The development of a
nephron involves a series of reciprocal tissue inductions
between the ureteric bud and the metanephric mesen-
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chyme. Induced metanephric mesenchyme cells condense
to form pretubular cell aggregates and go through a mes-
enchyme to epithelial transition and a series of morpho-
logical changes, including the formation of nephric
vesicles, comma- and S-shaped bodies and eventually the
formation of mature nephrons. A mature nephron is com-
posed of the vascular loop of the glomerulus, Bowman's
capsule, the proximal convoluted tubule, the loop of
Henle and the distal convoluted tubule that connects to
the drainage system. Genes expressed in developing and
mature nephrons may be important for their develop-
ment, structural integrity, and physiological function. In
humans, mutations in such genes may cause kidney dis-
ease [1].
Mouse has been widely used as a model organism for bio-
medical research. This is because the mouse is anatomi-
cally and physiologically similar to human. Recent
progress in the human and mouse genome projects fur-
ther indicates that the organization of these two mamma-
lian genomes are highly conserved [2]. Over 95% of
human genes can find their counterparts in the mouse
genome [3,4]. This high similarity between mouse and
human underscore the use of the mouse as the model
organism  par excellence for studies of many aspects of
human biology.
Although genes involved in kidney organogenesis or asso-
ciated with kidney disease have been identified, there is
still limited molecular genetic knowledge of kidney devel-
opment and homeostasis. Recent progress in microarray
technology provides a powerful tool to study the kidney
[5-14]. Mice with mutations that alter specific aspects of
kidney development and function provide unique tissue
resources for microarray studies [15-18].
Lim1, also called Lhx1, is a LIM-class homeobox gene that
is expressed in the ureteric bud and pretubular cell aggre-
gate prior to epithelialization of the developing metane-
phric kidney [19,20]. Most Lim1 null mutants die around
E10.5, an embryonic stage prior to the development of the
metanephros [21]. Rare Lim1-null mutant mice survive to
birth but do not have kidneys, demonstrating an essential
role for this gene in kidney organogenesis [21]. To bypass
the early lethality that hinders the analysis of Lim1 func-
tion in kidney organogenesis, a Lim1  conditional null
allele in mouse was generated [22]. An Rarb2-Cre trans-
gene was generated and used for metanephric mesen-
chyme-specific ablation of Lim1 that resulted in newborn
mice that had kidneys but no nephrons [20].
Nephrogenesis is a continuous process that begins with
the induction of metanephric mesenchyme by the ureteric
bud, around embryonic day 10.5 (E10.5), and persists
several weeks after birth in mice [1]. The first mature
nephron is observed at E16.5 [23]. Histological analysis
suggests that the development of Lim1 mutant nephrons
stops at the nephric vesicle stage, which begins around
E11.0. Loss of a nephric vesicle polarity marker, Brn1,
expression in the E13.5 conditional mutant kidneys fur-
ther indicated that the Lim1 is required for correct pattern-
ing of the nephric vesicle [20]. The developing nephric
vesicle represents an important developmental stage in
which nephron polarity is established. Disruption of its
patterning results in a failure to form nephron structures
such as proximal tubules and glomerular epithelium [24].
In this study, we hypothesized that Lim1 mutant nephron-
deficient kidneys could be used as a novel tissue resource
for microarray experiments to identify genes expressed in
the developing nephrons. Kidneys of two developmental
stages were examined. Control and conditional mutant
kidneys of E14.5 mouse embryos were used to identify
genes involved in early nephron development including
pattern formation. In contrast, E18.5 kidneys were used to
isolate functional genes that are expressed in mature
nephrons.
Methods
Generation of conditional mutant mice and genotyping
All procedures performed on animals were done in
accordance with guidelines of the American Physiological
Society and were approved by The University of Texas MD
Anderson Cancer Center Institutional Animal Care and
Use Committee (Richard R. Behringer, IACUC Protocol
Number: 02-90-01735). Mice carrying a targeted Lim1
null allele (Lim1lacZ, [25]), a Lim1 conditional null allele
(Lim1flox, [22]) and an Rarb2-Cre transgene in which Cre is
expressed in the metanephric mesenchyme of the devel-
oping kidney [20], were used in this study. Lim1lacZ/+ and
Lim1flox/flox mice were maintained on a C57BL/6J × 129/
SvEv genetic background. Rarb2-Cre transgenic mice were
initially generated on a C57BL/6J × SJL/J genetic back-
ground.
To obtain mouse embryos with metanephric mesen-
chyme-specific Lim1 deficient (Lim1flox/lacZ; Rarb2-Cretg/+)
kidneys, timed matings between Lim1+/lacZ; Rarb2-Cretg/+
males and Lim1flox/flox females were established. Kidney
samples of two different embryonic stages (E14.5 and
E18.5) were isolated. Their genotypes were assigned
unambiguously using real time PCR assays detecting the
presence of lacZ and Cre alleles, which were established in
the M. D. Anderson Cancer Center DNA Analysis Core
Facility. For the E14.5 time point, a total of 71 embryos
were collected, 17 of them were genotyped as conditional
mutants (Lim1flox/lacZ;  Rarb2-Cretg/+). Kidneys from 23
Lim1flox/+; Rarb2Cretg/+ embryos were used as "control" kid-
neys. For the E18.5 time point, a total of 39 embryos wereBMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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harvested, 9 of them were genotyped as conditional
mutants and 14 of them were genotyped as controls.
Tissue collection and RNA preparation
Embryonic kidney tissue from each individual was placed
in a separate tube with 0.5 ml TRIzol (Invitrogen,
Carlsbad, CA) and stored at -75°C until the correspond-
ing visceral tissue could be genotyped. After a genotype
was unambiguously assigned to each individual, TRIzol
preserved kidneys of the same genotype were pooled and
total RNA was prepared as per the manufacturer's instruc-
tions. Total RNA was then processed using a QIAGEN
RNeasy Midi Kit before in vitro transcription-labeling reac-
tion per Affymetrix (Santa Clara, CA) recommendation.
Once purified, RNA quality was determined by electro-
phoretic methods using an agarose gel or analysis using an
Agilent Bioanalyzer 2100 (Palo Alto, CA) and by spectros-
copy at 260 and 280 nm.
Microarray processing
Five to forty micrograms of total RNA from each pooled
embryonic kidney sample was used to produce the cRNA
target for the microarray. The target was created using a
reverse transcription reaction to produce cDNA (Super-
cript Choice System, Gibco), which was subsequently sub-
jected to in vitro transcription with biotinylated cytidine-
5'-triphosphate and uridine-5'-triphosphate using the
ENZO BioArray High Yield RNA Transcript Labeling Kit to
produce biotinylated cRNA. The target was then frag-
mented and hybridized to Mouse Genome 430 2.0
Affymetrix GeneChip Arrays (Affymetrix, Santa Clara, CA)
in duplicates using an Affymetrix GeneChip Fluidics Sta-
tion 400, according to the manufacturer's standard proto-
cols. The arrays were stained with phycoerythrin-coupled
avidin and scanned using a GeneArray Scanner 3000. The
resultant output was analyzed using Affymetrix Microar-
ray Suite software and examined for excessive background
or evidence of RNA degradation. All microarray process-
ing was performed in the Murine Microarray and Affyme-
trix Facility at the University of Texas M. D. Anderson
Cancer Center.
After scanning, all probe sets were scaled to a signal inten-
sity of 250 and relative levels of expression of each tran-
script (signal) were determined using Microarray Suite 5.0
software (Affymetrix). The images of all arrays were
inspected for physical anomalies and for the presence of
excessive background hybridization. Generally, all array
results used in this study were of good quality, and no
major manufacturer's defects or abnormalities were
detected.
Microarray analysis
Microarray experiment on each time point and genotype
was performed in technical duplicates (ie. a single RNA
preparation of pooled kidneys of one genotype used for
two separate target preparations). Data from a total of 8
independent arrays were used in this study, 2 arrays were
used for RNA samples from E18.5 control kidneys, 2 for
E18.5 Lim1 conditional mutant kidneys, 2 for E14.5 con-
trol kidneys, and the other 2 for E14.5 Lim1 conditional
mutant kidneys. Data generated from all arrays that satis-
fied the preliminary analysis were exported and loaded
into DNA-Chip Analyzer (dChip2004) [26,27], where sta-
tistical and comparative analyses were performed to verify
the data. The data were normalized using the default nor-
malization method. Briefly, an iterative procedure was
used to identify an invariant set of probes, which presum-
ably consisted of non-differentially expressed genes. A
piecewise-linear running median curve was then calcu-
lated and used as the normalization curve. After normali-
zation, all arrays had similar brightness. Median
intensities around 155 (between 155 to 158) were
obtained after normalization. Percent gene present (P
call%) values between 55.7% and 63.6% were observed
using default detection p-value cut offs (a1 = 0.04 and a2 =
0.06). Array outlier (%) and single outlier (%) were
detected at ranges from 0.016% to 0.080% and from
0.009% to 0.045%. Expression data obtained from all
arrays used is provided in Additional file 1.
Normalized data were exported in a tab delimited text for-
mat. Fold changes of each transcript from different sam-
ples were calculated and sorted using Microsoft Excel 5.0
software. Signal obtained from control kidney samples
were used as an experiment to compare to the signal
obtained from Lim1 conditional mutant kidneys that was
designated as a baseline. A 2-fold change in the means of
signal obtained from experimental duplicates and those
from baseline duplicates was used as the criterion to iden-
tify differentially expressed transcripts. To ensure the qual-
ity of the data, probe sets that showed a fold change
between duplicates greater than between the experimental
mean and baseline mean were removed. To study only
genes that showed consistent expression on experimental
chips, probe sets that did not show consistent present calls
in the experimental duplicates were removed. To focus on
genes with a significant fold change between the experi-
ment and the baseline, only probe sets that the product of
their experimental mean and fold change were more than
100 were retained. To produce a compact differentially
expressed gene list, the probe set list was sorted within
Microsoft Excel based on Locus Link number and redun-
dant entries were removed. Our experimental design
description and the data format provided in the Addi-
tional files fulfill the MIAME (minimum information
about a microarray experiment) standards [28].BMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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Expression specificity and ontological analysis
To evaluate kidney expression specificity of identified
genes, gene symbols and locus numbers were used to
retrieve their relevant expression information in the
Genomics Institute of the Novartis Foundation (GNF)
Gene Expression Atlas 2 and Unigene databases. The GNF
Atlas 2.0 contains two replicates each of 61 mouse tissues
run over Affymetrix probe arrays. It was accessed using the
Gene Sorter server provided by the University of Califor-
nia at Santa Cruz [29]. Gene Sorter provides a score,
between -4 to 4, to describe the relative expression level of
a gene in different tissues presented in the GNF Atlas 2
[30]. In contrast Unigene is a system automatically parti-
tioning GenBank sequences, including expressed
sequence tags (ESTs), into a non-redundant set of gene-
oriented clusters [31]. The Unigene data were obtained
from SOURCE [32], which provides a normalized expres-
sion level, based on the number of ESTs within the cluster
found in cDNA libraries of different sources, expressed in
percentages, to represent the relative abundance of a tran-
script in different tissues or organs [33]. To understand
the composition of the genes identified in our study,
ontological analysis was performed using DAVID (Data-
base for Annotation, Visualization and Integrated Discov-
ery) and EASE (Expression Analysis Systematic Explorer)
from the National Institute for Allergy and Infectious Dis-
ease (NIAID) [34-37]. Data obtained were processed and
charts were drawn using Microsoft Excel 5.0 software.
Results
Identification of stage-specific kidney genes
The first protocol used was to compare gene expression
levels in kidney samples of the two developmental stages
so that stage-specific kidney genes could be identified. To
enrich for E18.5 kidney-specific genes, signals obtained
from E18.5 control kidney samples (E18.5C) were used to
compare with E14.5 control kidney data (E14.5C). Genes
sorted according to their expression signal fold changes
(E18.5C/E14.5C) generated a list enchriched for E18.5
mouse kidney genes. A list of 1,006 genes showed more
than 2 fold change was identified (Table 1 and Additional
file 2). As shown in Table 2, the enrichment for kidney
specificity was dramatic. The average relative kidney
expression level among the top 50 genes on the list
reported by Gene Sorter is 3.6 whereas that of the gene list
sorted using raw signals (E18.5C) is only -0.1. Similarly
the average normalized expression level in the kidney,
reported by SOURCE [33], of the top 50 genes also
showed a nearly 15 fold increase (30.69% compare to
2.07%). Although a PubMed search did not find any of
the top 50 genes in the list sorted by raw signals (E18.5C;
0%), 22 of the top 50 (44%) genes sorted by fold change
(E18.5C/E14.5C) were described to have a nephron-spe-
cific expression pattern.
The same approach was applied to the E14.5 experiment
to identify 796 gene that showed more than a 2 fold
change (Table 1 and Additional file 3), however the
enrichment for kidney- or nephron-specificity was not sig-
nificant. As shown in Table 2, the average relative kidney
expression levels of the top 50 genes were not much dif-
ferent in lists sorted by the raw signals and fold changes (-
0.1 and 0.0). A slight increase in the average normalized
expression in the kidney was observed (1.48% and
2.51%). There were only 2 genes (4%) among the top 50
reported to have a nephron-specific expression pattern in
Table 1: Numbers of genes that showed more than a 2-fold increase in different expression level comparisons.
Experiment/Baseline E18.5 C E18.5 M E14.5 C E14.5 M
E18.5 C - 47 796 -
E18.5 M 465 - 481 341
E14.5 C 1,006 476 - 2
E14.5 M - 331 41 -
Table 2: Expression profile comparison between E18.5 control and Lim1 conditional mutant kidney generated a gene list enriched for 
nephron-specificity.
Sorted by Relative kidney expression level 
(GNF 2.0)




E18.5 C -0.1 2.07% 0%
E18.5 C/E14.5 C 3.6 30.69% 44%
E18.5 C/E18.5 M 3.5 32.27% 56%
E14.5 C -0.1 1.48% 0%
E14.5 C/E18.5 C 0.0 2.51% 4%
E14.5 C/E14.5 M 2.9 21.51% 26%BMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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Table 3: Top 50 genes upregulated in the E18.5 control kidney when compared to the Lim1 conditional mutant kidney.
Gene Name Locus Link Symbol Fold Change GNF 2.0 SOURCE (%) Nephron -specific Reference
Solute carrier family 34, member 1 20505 Slc34a1 63.47 4.0 78.05
Uromodulin 22242 Umod 58.19 4.0 61.91 HL,DT [54]
Calbindin 3 12309 Calb3 45.16 4.0 11.13 DT [55]
Glutathione S-transferase, alpha 2 14858 Gsta2 41.30 4.0 31.73 PT [56]
Hydroxyacid oxidase 3 56185 Hao3 40.21 4.0 24.19
Nephrosis 2 homolog, podocin 170484 Nphs2 39.83 2.0 71.88 Pod [57]
Kidney-specific membrane protein 57394 Tmem27 37.83 4.0 36.97 DN,DT, PT, UT [14]
MGC37245 233799 MGC37245 36.09
Cytochrome P450, family 2, subfamily j, 
polypeptide 5
13109 Cyp2j5 36.03 4.0 15.60
FXYD domain-containing ion transport 
regulator 2
11936 Fxyd2 35.57 4.0 69.12 PT, HL [58]
Klotho 16591 Kl 35.49 4.0 53.50 PT [59]
Kidney androgen regulated protein 16483 Kap 35.36 4.0 40.76 PT [60]
Hydroxysteroid dehydrogenase-4, delta<5>-
3-beta
15495 Hsd3b4 34.28 4.0 50.43
Fructose bisphosphatase 1 14121 Fbp1 32.04 4.0 18.74 DN,DT, PT,UT [61]
Gamma-glutamyltransferase 1 14598 Ggt1 30.65 4.0 17.68 PT [62]
Solute carrier family 5, member 8 216225 Slc5a8 29.22 13.49
Solute carrier family 26, member 1 231583 Slc26a1 27.27 3.0 14.30 PT [63]
Low density lipoprotein receptor-related 
protein 2
14725 Lrp2 25.73 51.68 PT,Gl [64]
Aldolase 2, B isoform 230163 Aldo2 23.80 4.0 37.02 PT [65]
Kynurenine aminotransferase II 23923 Kat2 23.35 4.0 67.29
Cubilin 65969 Cubn 22.94 3.0 5.18 PT [66]
Solute carrier family 12, member 1 20495 Slc12a1 22.45 4.0 74.20 HL [67]
RIKEN cDNA D630043A20 gene 207151 Slc22a19 21.95 4.0 81.09
RIKEN cDNA 0610038O04 gene 75396 061003800
4Rik
21.91
Phenylalanine hydroxylase 18478 Pah 21.25 4.0 28.04 PT [68]
Sulfotransferase family 1D, member 1 53315 Sult1d1 20.47 10.49
Betaine-homocysteine methyltransferase 2 64918 Bhmt2 20.26 2.5 5.80 PT [69]
Serine (or cysteine) proteinase inhibitor, 
clade A, member 6
12401 Serpina6 19.94 0.5 2.56
Glycine amidinotransferase 67092 Gatm 19.69 4.0 6.83
Fatty acid binding protein 3 14077 Fabp3 19.60 2.0 4.22
RIKEN cDNA 9130022A01 gene 100061 9130022A0
1Rik
18.71 4.0
UDP-glucuronosyltransferase 1 family, 
member 2
22236 Ugt1a2 18.42 4.0
Amnionless 93835 Amn 17.98 3.0 4.01 PT,DT [14]
Cytochrome P450, family 27, subfamily b, 
polypeptide 1
13115 Cyp27b1 17.91 0.5 98.60 PT [70]
Potassium inwardly-rectifying channel, 
subfamily J, member 15
16516 Kcnj15 17.69 43.57 RT [70]
Claudin 2 12738 Cldn2 17.10 4.0 8.61 PT [71]
RIKEN cDNA 2010002A20 gene 66601 2010002A2
0Rik
16.99 4.0 20.30
Defensin beta 1 13214 Defb1 16.78 4.0 34.83 CT,HL [72]
Kidney-derived aspartic protease-like 
protein
16541 Kdap 16.76 4.0 38.24 PT [73]
Serine protease inhibitor, Kazal type 3 20730 Spink3 16.30 4.0 1.13
Hepatic nuclear factor 4 15378 Hnf4 16.20 3.5 5.37 UD,Gl,RV [74]
Solute carrier family 22, member 6 18399 Slc22a6 15.71 2.5 26.67 DN,PT,Gl [14]
PDZ domain containing 1 59020 Pdzk1 15.49 4.0 33.70 PT [75]
Kallikrein 6 16612 Klk6 15.46 4.0 14.16 UT [76]




Alanyl aminopeptidase 16790 Anpep 14.96 2.5 9.70 PT [77]
Meprin 1 alpha 17287 Mep1a 14.77 3.0 59.06
Argininosuccinate synthetase 1 11898 Ass1 14.26 4.0 35.65 PT [78]
Meprin 1 beta 17288 Mep1b 14.13 4.0 2.00
Abbreviations: CT, collecting tubule; DN, developing nephron; DT: distal convoluted tubule; Gl: glomerulus; HL, loop of Henle; PT, proximal 
convoluted tubule; Pod, podocyte; RT, renal tubule; RV: renal vesicle; UD, ureteric duct; UT, ureteric tubule.BMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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the gene list sorted by developmental stage-specific fold
change (E14.5C/E18.5C). A closer look of the gene list
revealed that this list enriched for genes generally
expressed in undifferentiated, embryonic tissues but do
not necessarily show kidney-specificity (data not shown).
Identification of nephron-specific genes of different 
developmental stages
A second protocol was to take advantage of the nephron-
deficient  Lim1  conditional mutant kidneys to identify
nephron-specific genes of different developmental stages
[20]. To generate an E18.5 nephron-specific gene list, we
compared gene expression data of E18.5 control kidney
(E18.5C) and Lim1 conditional mutant kidney (E18.5M).
Fold changes were calculated and used to sort genes. A
total of 465 genes showed a more than 2 fold increase in
expression in the control kidney compared to the condi-
tional mutant kidney (Table 1 and Additional file 4). The
top 50 genes on the list were further evaluated computa-
tionally for their kidney specificity. The results indicate
that the gene list generated by this protocol is highly
enrich for nephron-specific genes. The average relative
kidney expression level, based on GNF 2.0, reached 3.5,
and the normalized kidney expression level, according to
SOURCE, is 32.27%. There is also a slight increase in the
ratio of genes with published nephron-specific expression
patterns (56%) compared to the gene list generated using
the previous protocol (44%). The details of the gene list
are described in Table 3.
A gene list enriched for E14.5 nephron-specific genes was
generated using the same protocol. Comparison of the
E14.5 control kidney and Lim1 conditional mutant kid-
ney gene expression profile picked up only 41 genes that
showed a more than 2 fold change (Table 1). Unlike the
gene list sorted by the comparison made between devel-
opmental stages (E14.5C/E18.5C), which does not signif-
icantly enrich for E14.5 kidney genes, the comparison
between control and Lim1  conditional mutant kidney
helped to identify kidney-specific genes, especially those
expressed in the nephrons. As shown in Table 2, the aver-
age relative kidney expression level is as high as 2.9, and
there is also a nearly 15 fold increase in the average nor-
malized kidney expression level (21.51 % compare to
1.48%). Thirteen (26%) genes on the top 50 list were also
previously described to have a nephron-specific expres-
sion pattern. Notably 3 genes related to the Notch signal-
ing pathway, Msih2, Hes5, and Jag1 were found in the list.
The details of this gene list are summarized in Table 4.
Ontological analysis on nephron-specific genes of different 
developmental stages
To gain insight into the functional aspects of the microar-
ray data, we exploited the web-based annotation tool,
DAVID, to help identify functional themes that showed
differences between the control kidney and the Lim1 con-
ditional mutant kidney [36]. Each of the top 1,000 genes
on the lists that displayed upregulation in the control kid-
ney compared to the Lim1 conditional mutant kidney at
either E18.5 or E14.5 were used for this analysis. Ontolog-
ical analyses were performed at Molecular Function Level
1, Biological Process Level 2, and Cell Component Level 4
[35]. The results of major functional categories are shown
in Figure 1. The numbers of genes that fell in major cate-
gories were normalized by the number of genes annotated
in each list and were expressed in percentages. Generally
speaking nephron-specific genes identified at E18.5 were
better studied. Close to 60% of these genes were anno-
tated in Molecular Function and Biological Process ontol-
ogies and 32% in Cell Component at the levels our
analyses were performed. In contrast, only about 30% and
11% of the genes on the E14.5 nephron-specific gene list
were annotated at the same levels.
Comparisons made at Molecular Function Level 1 (Figure
1A) revealed that the majority of the E18.5 nephron genes
identified in our screen were described to possess catalytic
activity (58.49%) whereas molecules found in the E14.5
nephron gene list were better studied for their physical
interactions with other molecules (e.g. binding, 64.48%).
The E18.5 gene list is also characterized by a relatively
high proportion of transporter proteins (25.79%)
whereas the E14.5 gene list contains a higher ratio of
genes with signal transducer (13.73%), transcription reg-
ulator (8.06%), enzyme regulator (4.48%), motor
(1.19%) and translation regulator (0.90%) functions.
Ontological analysis at Biological Process Level 2 (Figure
1B) indicated that the E14.5 nephron-specific gene list
favors molecules involved in cell communication
(20.79%) and morphogenesis (11.11%). Metabolism is
detected as a very significant functional theme in the
E18.5 gene list with an EASE score of 7.72 E-5 (data not
shown) [37].
Cell Component Level 4 ontological study (Figure 1C) of
E18.5 nephron-specific genes featured by a high propor-
tion of genes identified at subcellular sites related to
energy metabolism, including mitochondria (46.27%),
mitochodrial inner membrane (13.04%), electron trans-
fer flavoprotein complex (0.93%), hydrogen-translocat-
ing V-type ATPase complex (1.24%), proton-transporting
ATP synthase complex (2.80%), proton-transporting two-
sector ATPase complex (3.11%), respiratory chain com-
plex III (0.93%), respiratory chain complex IV (1.86%),
and ubiquinol-cytochrome-c reductase complex (0.93%).
There were also more proteins found at the vacuole
(5.59%), microbody (4.04%) and vesicular fraction
(3.11%). However, a higher proportion of proteins in the
cytoskeleton (18.52%), Golgi apparatus (12.96%), nucle-BMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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oplasm (12.96%), cytosol (11.11%), chromatin (3.70%)
and basal lamina (2.78%) was found in the E14.5 gene
list.
Discussion
The mouse is one of the most widely used animal models
to study human biology especially after the development
of embryonic stem (ES) cells and the assembly and anno-
tation of the mouse genome sequence [2-4,38]. ES cells
and gene targeting technology allow the construction of
transgenic mice with defined genetic modifications. The
availability of whole genome sequences forms the basis of
the development of high-throughput technologies, such
as microarrays, to conduct research at a genomic level.
Since it is relatively difficult to collect significant numbers
of genetically well-defined human samples, it is impor-
Table 4: Top 41 genes upregulated in the E14.5 control kidney when compared to the Lim1 conditional mutant kidney.
Gene Name Locus Link Symbol Fold Change GNF 2.0 SOURCE (%) Nephron -specific Reference
Sulfotransferase family 1D, member 1 53315 Sult1d1 7.22 10.49
Hydroxyacid oxidase 3 56185 Hao3 7.05 4.0 24.19
FXYD domain-containing ion transport 
regulator 2
11936 Fxyd2 5.71 4.0 69.12 PT,HL [58]
Hepatic nuclear factor 4 15378 Hnf4 5.70 3.5 5.37 UD,DG,RV [74]
Kidney-specific membrane protein 57394 Tmem27 4.26 4.0 36.97 DN,DT, PT,UT [14]
Sclerostin domain containing 1 66042 Sostdc1 4.16 3.5 12.36 DT [79]
Lymphocyte antigen 6 complex, locus A 110454 Ly6a 4.05 2.5 7.10
AW210596 240638 AW210596 3.38 4.0 5.03
Aldolase 2, B isoform 230163 Aldo2 3.27 4.0 37.02 PT [65]
RIKEN cDNA 9930038N01 gene 9930038N01Rik 3.13
RIKEN cDNA 0610033E06 gene 112417 0610033E06Rik 3.07 3.5 37.77
Musashi homolog 2 76626 Msi2h 2.87 1.12
ATPase, Na+/K+ transporting, beta 1 
polypeptide
11931 Atp1b1 2.83 2.5 8.64
Hairy and enhancer of split 5 15208 Hes5 2.67 0.5 0.00 CB,SB, PT [40]
RIKEN cDNA 1300013J15 gene 67473 1300013J15Rik 2.55 4.0 32.54
BC013481 245945 BC013481 2.51 1.72
PDZ domain containing 1 59020 Pdzk1 2.51 4.0 33.70 PT [75]
RIKEN cDNA D630042F21 gene 330428 D630042F21Rik 2.50 70.39
Glucosaminyl (N-acetyl) transferase 1, 
core 2
14537 Gcnt1 2.45 5.38
Dipeptidylpeptidase 4 13482 Dpp4 2.38 PT,DT [80]
Low density lipoprotein receptor-
related protein 2
14725 Lrp2 2.37 51.68 PT,Gl [64]
Purkinje cell protein 4 14858 Pcp4 2.35 -2.0 0.00
Glutathione S-transferase, alpha 2 18546 Gsta2 2.35 4.0 31.73 PT [56]
MGC37245 233799 MGC37245 2.29
BB427389 BB427389 2.28
Single-minded 1 20464 Sim1 2.27 2.5 0.00 RT 81
Kidney expressed gene 1 64697 Keg1 2.26 4.0 49.76
BG064527 BG064527 2.24
RIKEN cDNA 2610511G16 gene 67500 2610511G16Rik 2.20
Nephrosis 2 homolog, podocin 170484 Nphs2 2.20 2.0 71.88 Pod 57
Solute carrier family 34, member 1 20505 Slc34a1 2.16 4.0 78.05
RIKEN cDNA 2700008B19 gene 217026 2700008B19Rik 2.15 1.76
RIKEN cDNA 6332401O19 gene 319832 6332401O19Rik 2.14 6.71
RIKEN cDNA 9130423L19 gene 74570 9130423L19Rik 2.11 1.5
C85657 C85657 2.11
RIKEN cDNA 5730493B19 gene 5730493B19Rik 2.10
Fucosyltransferase 9 14348 Fut9 2.10 4.0 3.15
AU022045 AU022045 2.07
Jagged 1 16449 Jag1 2.06 1.5 1.20 RV, CB, SB,PT [82]
EH-domain containing 2 259300 Ehd2 2.02 0.00
RIKEN cDNA 2610510D13 gene 229279 2610510D13Rik 2.01 -0.5
Abbreviations: CB, comma-shaped body; CT, collecting tubule; DN, developing nephron; DG, developing glomerulus; DT: distal convoluted tubule; 
Gl: glomerulus; HL, loop of Henle; PT, proximal convoluted tubule; Pod, podocyte; RT, renal tubule; RV: renal vesicle; SB, S-shaped body; UD, 
ureteric duct; UT, ureteric tubuleBMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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tant to perform research on an evolutionarily close species
prior to their human applications. In this study, we took
advantage of the nephron-deficient kidneys from metane-
phric mesenchyme-specific Lim1 conditional mutant mice
to perform a genome-wide screen for developing nephron
genes. Whereas similar studies have been performed on
kidneys from meprin β, vitamin D receptor, aquaporin-1,
or metallothionein knockout mice, our study is the first to
use a tissue-specific approach in the kidney [15-18].
Computational analysis and PubMed search suggested
that the expression profile comparison between control
and Lim1 conditional mutant kidneys generated gene lists
enriched for nephron-specific genes. In global gene
Ontological analyses of the top 1,000 genes upregulated in E18.5 and E14.5 control kidneys Figure 1
Ontological analyses of the top 1,000 genes upregulated in E18.5 and E14.5 control kidneys. A. Molecular Function 
Level 1 analysis (annotation rates: E18.5 – 63.6%, E14.5 – 33.5%). B. Biological Process Level 2 analysis (annotation rates: E18.5 
– 54.0%, E14.5 – 27.9%). C. Cell Component Level 4 analysis (annotation rates of the top 1,000 genes: E18.5 – 32.2%, E14.5 – 
10.8%). Only molecule categories containing at least 3 hits in either of the gene lists are shown. The numbers of genes fell in 
major functional categories were normalized by the numbers of gene annotated in each list and were expressed in percentages.BMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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expression level studies, ribosomal genes and other
housekeeping genes that are highly expressed but do not
show any tissue- or developmental stage-specificity are
always identified. In this study, we used two different pro-
tocols to enrich for developmental stage-specific kidney
genes and nephron-specific genes of different develop-
mental stages. Two independent online gene expression
databases, namely GNF Expression Atlas 2.0 and Unigene
were used to evaluate the tissue-specific enrichment com-
putationally. Our results indicated dramatic enrichments
for kidney-specific genes by both protocols in the E18.5
experiments. However, the comparison made between
E14.5 and E18.5 control kidneys did not generate a kid-
ney-specific gene list. In our opinion, there are at least two
possible reasons. Firstly, data from the two online data-
bases we used were based on experiments performed
using either adult or neonate kidney tissues. Neither of
them are likely to reflect gene expression profiles during
early nephron development. Secondly, since many impor-
tant molecular pathways and fundamental developmen-
tal processes are repeatedly observed in different organ
systems, genes predominantly expressed during early
nephron development are also likely to be found in other
undifferentiated tissues. A closer look of the gene list
results in a conclusion consistent with this latter assump-
tion. Many of the genes identified by this comparison are
commonly found in undifferentiated tissues (data not
shown). In contrast, the comparison between E14.5 con-
trol and Lim1 conditional mutant kidneys identified mol-
ecules that are also found in mature nephrons, which
predominantly contributed to the kidney-specificity in
our evaluation, and molecules involved in early nephron
development. For example, podocin  (Nphs2) is only
expressed in terminally differentiated podocytes [39]. Ele-
vated podocin level observed in E14.5 control kidney sug-
gests that the first podocyte is found before or around
E14.5. Notably, regulatory genes important in early neph-
ron development, such as Msi2h, Hes5, and Jag1, which
are involved in Notch signaling [40-45], do not show kid-
ney-specificity based on GNF Atlas 2.0 and UniGene data.
However, our screening protocol placed them on top of
our list. Therefore, the use of Lim1 conditional mutant tis-
sue as an RNA source in our microarray experiment
helped to identify nephron developmental genes.
The results of our ontological comparison made between
the E18.5 and E14.5 nephron-specific gene lists are con-
sistent with current concepts of kidney organogenesis and
a previous study [46,47]. Gene ontology (GO) annota-
tions provide structured, precisely defined, common, con-
trolled vocabulary for describing the roles of genes and
their products in any organism. It is the current represen-
tation of biological knowledge as well as serving as a guide
for organizing new data [35]. However, one should keep
in mind that the gene ontology is a dynamic, web-based
resource, the annotations are not complete and their accu-
racy is limited by current knowledge of the molecules.
Although kidney organogenesis is a continuous process,
the first nephron is not seen until around E16.5 [1,23].
Nephrons forming in a E14.5 kidney are mainly com-
posed of reciprocally induced tissues, stem cell growth
and differentiation, cell polarization, mesenchyme to epi-
thelia transformation, branching morphogenesis, angio-
genesis, apoptosis, proximal-distal segmentation and the
differentiation of several interesting cell types. In our
oncological analysis, E14.5 forming nephron-specific
genes are composed of those better studied for their pro-
tein-protein interaction (binding) and possess signal
transducer, transcription regulator and enzyme regulator
activities. A higher portion of them are involved in cell
communication and morphogenesis process. Interest-
ingly, they are associated with cytoskeleton and nuclear
compartments (nucleoplasm and chromatin). In contrast,
there are many mature nephrons present in an E18.5 kid-
ney. Therefore, we were expecting to observe genes related
to kidney function, e.g. those involved in solute transport
and energy metabolism. Our results indicate a relatively
high number of E18.5 nephron-specific genes possess cat-
alytic activity (presumably related to energy metabolism
and the extensive extracellular matrix change in late kid-
ney development) and exert their function as transporters.
Consistently, an extremely high proportion of them
encoded proteins located in the mitochondria.
Ontological analysis and a detailed examination of the
top 1,000 E14.5 nephron-specific gene list suggest that
genes with modest upregulation in the control kidney
(fold changes less than 2 in our experiment) are also inter-
esting. For example, Brn1 (1.34) and EphA4 (1.67) were
previously shown to be downstream of Lim1 [20,25]. Fzd4
(1.71) has been considered a candidate receptor to trans-
duce Wnt4 signals during kidney organogenesis [1,48].
Irx2 (1.52) and Irx3 (1.28) are homeobox genes previ-
ously reported to be expressed in the developing neph-
rons [49]. Crb3  (1.40) is known to localize to kidney
epithelia and is essential for ciliogenesis [50,51]. The top
1,000 genes upregulated in the E14.5 control kidney is
supplied in Additional file 5.
Tissue heterogeniety always complicates the interpreta-
tion of microarray data although analyses of different
organs or even on organisms of different developmental
stages have been reported [30,52]. In our experiment, we
used the whole kidney as a tissue source for RNA prepara-
tion. The complexity of kidney structure and development
limits interpretations of our results. Improvements in tis-
sue collection methods such as laser capture microdissec-
tion and fluoresence-activated cell sorting (FACS) on
genetic marked/fluorescent protein-labelled transgenic
tissue have been developed [14,53] and could provideBMC Nephrology 2006, 7:1 http://www.biomedcentral.com/1471-2369/7/1
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more specificity. Nevertheless, our study demonstrates
that genetically engineered mouse organs can be used to
identify tissue-specific and developmentally regulated
genes during mammalian organogenesis.
Conclusion
Our experimental results indicate that the expression pro-
file comparisons between the control and the Lim1 condi-
tional mutant kidneys generated nephron-specific gene
lists. Our results demonstrate the feasibility of exploiting
genetically engineered kidneys to identify developing
nephron-specific genes.
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